2019 PET/CT Imaging – A Video CME Teaching Activity

• Apply state-of-the-art protocols to evaluate neurodegenerative disease, head and neck and cutaneous cancers to clinical practice.
• Optimize PET and PET/CT imaging protocols for the detection and follow up of lymphoma and musculoskeletal tumors.
• Describe the advantages and pitfalls of PET and PET/CT.
• Differentiate normal variants and urgent findings on PET/CT.
• Discuss the utility of PET/CT when used to evaluate cardiac disease, gastrointestinal, thyroid and prostate cancers.

Program

Session 1

PET/CT Techniques and Reporting Principles
Eric M. Rohren, M.D., Ph.D.

PET/CT for Neurodegenerative Diseases
Gagandeep Choudhary, M.D.

PET/CT in Cardiology
Robert M. Bober, M.D., FACC

Session 2

PET/CT in Head and Neck Cancer
Don C. Yoo, M.D., FACR

PET/CT for Non-Neurodegenerative Diseases
Gagandeep Choudhary, M.D.

PET/CT in Thyroid Cancer
Mark Tulchinsky, M.D., FACNM

Ga-68 and Lu-177 DOTATATE in Neuroendocrine Tumors
Katherine Zukotynski, M.D.

Session 3

PET/CT in Malignancy of the Lung
Don C. Yoo, M.D., FACR

PET/CT in Malignancy of Female Breast and Pelvis
Katherine Zukotynski, M.D.

Qualitative and Quantitative Response Criteria
Eric M. Rohren, M.D., Ph.D.

Session 4

PET/CT in Infection and Inflammation Imaging
Don C. Yoo, M.D., FACR

PET/CT in Gastrointestinal Malignancies
Eric M. Rohren, M.D., Ph.D.

PET/CT in Skeletal Tumors: Primary and Metastatic
Katherine Zukotynski, M.D.

Session 5

PET/CT in Lymphomas
Mark Tulchinsky, M.D., FACNM

PET/CT in Prostate Cancer
Eric M. Rohren, M.D., Ph.D.

PET/CT in Cancers of the Skin
Mark Tulchinsky, M.D., FACNM